FDA Inspection 1271769 — Seqirus Inc

Seqirus Inc — FEI 3007867647

The FDA completed an inspection of Seqirus Inc on June 5, 2025 in Holly Springs, NC. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 5, 2025
Fiscal Year
2025
Product Type
Biologics
Project Area
Vaccines and Allergenic Products
Location
Holly Springs, NC (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
136121 CFR 211.100(a)Absence of Written Procedures